Stock image Protease Inhibitor
Concept Of A New Oral Antiviral Therapeutic Treatment For Covid-19 Virus
Image, 4.85MB, 4305 × 5000 jpg
The Antimalaria Agent Chloroquine Is Considered A Potential Drug Against Sars-CoV-2 Infections..
Image, 2.31MB, 8000 × 6000 jpg
The Protease Inhibitor Camostat Is A Potential Candidate For The Treatment Of Sars-CoV-2 Infections.. It Blocks The Entry Of The Virus In Human Cells.
Image, 9.53MB, 8000 × 6000 jpg
The Nucleotide Analogue Remdesivir And The Protease Inhibitor Camostat Are Potential Drugs Against Sars-CoV-2 Infections..
Image, 3.63MB, 8000 × 6000 jpg
Concept Of A New Oral Antiviral Therapeutic Treatment For Covid-19 Virus
Image, 4.56MB, 5000 × 3716 jpg
The Coronavirus 3CL Hydrolase Enzyme With An Inhibitor Bound In The Active Site
Image, 2.32MB, 8000 × 6000 jpg
Structure Of Human Pepsin Complexed With Inhibitor Pepstatin, 3D Cartoon Model Isolated, White Background
Image, 2.07MB, 4096 × 4096 jpg
Structure Of The SARS-CoV-2 (COVID-19) Main Protease (green) In Complex With Two Molecules Of The UAW241 Inhibitor (brown), 3D Cartoon Model Isolated, White Background
Image, 2.79MB, 4096 × 4096 jpg
Pills, Drugs, Medictions And Suppositories In Blister Package And Medical Stethoscope In Two Colors Background: Blue And Pink. Concept Of Drug Therapy, Treatment, Curing Diseases Of Men And Women
Image, 8.2MB, 6000 × 4000 jpg
Lopinavir, C37H48N4O5, Molecule. It Is An Antiretroviral Protease Inhibitor, Used In With Ritonavir In The Therapy Of Human Immunodeficiency Virus HIV Infection And Acquired Immunodeficiency Syndrome AIDS, 2019-ncov. Vector
Vector, 1.11MB, 5916 × 4226 eps
Page 1 >> Next